Does DORZOLAMIDE\TIMOLOL Cause Product packaging quantity issue? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Product packaging quantity issue have been filed in association with DORZOLAMIDE\TIMOLOL. This represents 1.1% of all adverse event reports for DORZOLAMIDE\TIMOLOL.
51
Reports of Product packaging quantity issue with DORZOLAMIDE\TIMOLOL
1.1%
of all DORZOLAMIDE\TIMOLOL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From DORZOLAMIDE\TIMOLOL?
Of the 51 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DORZOLAMIDE\TIMOLOL. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does DORZOLAMIDE\TIMOLOL Cause?
Treatment failure (773)
Eye irritation (764)
Drug ineffective (583)
Ocular hyperaemia (581)
Eye pruritus (383)
Eye pain (324)
Vision blurred (267)
Eye swelling (232)
Death (216)
Hypersensitivity (189)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which DORZOLAMIDE\TIMOLOL Alternatives Have Lower Product packaging quantity issue Risk?
DORZOLAMIDE\TIMOLOL vs DOSTARLIMAB
DORZOLAMIDE\TIMOLOL vs DOSTARLIMAB-GXLY
DORZOLAMIDE\TIMOLOL vs DOTATATE GALLIUM GA-68
DORZOLAMIDE\TIMOLOL vs DOTHIEPIN
DORZOLAMIDE\TIMOLOL vs DOXAZOSIN